With investors going cold on China artificial intelligence, Evomotion has remained popular and profitable by delivering hardware and software to corners of the market that are either overlooked or hard to access
SenseTime might be China’s most valuable artificial intelligence (AI) technology developer, but its journey from private to public ownership was fraught with difficulty. A New York IPO was thwarted by...
India’s Innoven Capital, a joint venture between UOB and Temasek Holdings-owned Seviora Holdings, has fractionalised a USD 50m venture debt fund using blockchain and smart contracts.
OneVentures and UniQuest have led a AUD 34m (USD 23m) funding round for Vaxxas, an Australia-based biotechnology company running clinical programmes that include a needle-free COVID-19 vaccine candidate.
Temasek Holdings, A91 Partners, and Kae Capital have invested USD 135m in Indian omnichannel wellness products retailer HealthKart.